Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use
Utsav Joshi, Faustine Ong, Chikwe Joanna, Andreas Saltos et autres
7 citationsClinical Lung Cancer
Alberto Chiappori
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
257Publications signalées
17068Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Research StudiesLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentAdenosine and Purinergic Signaling
Publications récentes
A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non–small cell lung cancer
Hirva Mamdani, Ryan D. Gentzler, Lin Gu, Alberto Chiappori et autres
3 citationsCancer
MA11.01 Phase 1 Study of DLL3-Targeted CAR-T Cells Armored With dnTGFBR2 in Small-Cell Lung and Large-Cell Neuroendocrine Cancers
A.J. Schoenfeld, Alberto Chiappori, Ben Creelan, Reinhold Munker et autres
2 citationsJournal of Thoracic Oncology
Real World Safety of Tarlatamab Step-Up Dosing in Extensive Stage Small Cell Lung Cancer
Faustine Ong, Utsav Joshi, Daniel J. Melzer, Chikwe Joanna et autres
2 citationsJournal of Thoracic Oncology
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING
Yoo Sun Kim, Barzin Y. Nabet, Briana Cortez, Nai-Yun Sun et autres
8 citationsJournal of Clinical Investigation
Safety, tolerability, and preliminary efficacy results of a phase 1 study of LB2102, a dnTGFβRII armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC).
Jacob Sands, Alberto Chiappori, Ben Creelan, Paul Schwarzenberger et autres
6 citationsJournal of Clinical Oncology
Abstract 6404: NOTCH1 drives immunogenicity through STING and improves survival with immune checkpoint blockade in small cell lung cancer
Yoo Sun Kim, Barzin Y. Nabet, Briana N. Cortez, Nai-Yun Sun et autres
0 citationsCancer Research
120MO Inupadenant combined with chemotherapy in patients with non-squamous NSCLC progressing on or after immune checkpoint inhibitor therapy: Results from dose-finding part of the A2A-005 trial
Kristof Cuppens, G. Lo Russo, Óscar Juan, E. Felip et autres
0 citationsImmuno-Oncology Technology
1487 Results from a phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non-small cell lung cancer
Jeffrey Clarke, Ryan D. Gentzler, Lin Gu, Alberto Chiappori et autres
0 citations
P1.06B.05 Utility of Molecular Tumor Board Driven by Precision Medicine Service and Cloud-Based Datamart for Therapy and Trial Matching
J. Kevin Hicks, Andreas Saltos, A. Aminpour, Alberto Chiappori et autres
0 citationsJournal of Thoracic Oncology
MA17.11 NOTCH1 Expression Is Associated with Overall Survival in Small Cell Lung Cancer Patients Treated with Atezolizumab in IMpower133
Yongsoo Kim, Barzin Y. Nabet, Huann‐Sheng Chen, Alberto Chiappori et autres
1 citationJournal of Thoracic Oncology
P1.13A.13 ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study
T. Owonikoko, T.F. Burns, Alberto Chiappori, Benjamin J. Drapkin et autres
2 citationsJournal of Thoracic Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.